Navigation Links
Drugstore of the future -- new drugs from an old source
Date:11/10/2010

Toronto, ON (Nov. 10 2010) Supported by thousands of years of use, a new wave of polymolecular botanical drugs (PBDs), backed by strong biomedical research and clinical trials, are growing in acceptance as a viable new drug category for the treatment and prevention of a wide spectrum of diseases from cancer to obesity.

Leading researchers in drug development from the National Cancer Institute, Wake Forest University, the University of California, the Scripps Centre for Integrative Medicine, King's College in London UK, and many Canadian Universities will be among the twenty panellists at a Toronto forum on November 15th. Speakers will highlight recent discoveries, discuss current and future research, and chart regulatory landscapes for the promising field of polymolecular drug development. Treatment areas include diabetes, cholesterol management, and cancer.

Research findings will be presented illustrating the advances in the development of polymolecular drugs and their growing recognition as potential mainstream therapies to not only treat illness, but to prevent it. Since polymolecular drugs are composed of multiple components, they often produce biological and/or clinical efficacy through multiple mechanisms of action rather than through a single pathway, as conventional drugs do. An added advantage of this new class of drugs is the synergy between their components, which allows for lower concentrations of each individual ingredient with no reduction in efficacy. As a result they are, as a category, safer and more tolerable than conventional drugs.

Discussion will also focus on recent successes in standardization, which overcome the greatest challenge of botanical medicine and allow for assurances of consistency, safety, and efficacy.

The list of speakers at the forum will include:

  • Dr. Erminia Guarneri, founder and medical director of the Scripps Center for Integrative Medicine, who will deliver the keynote address, titled Personalized, Predictive, Pro-Active Health: Treating the Whole Person, Body, Mind & Spirit
  • Dr. Pierre Haddad, Professor at the University of Montreal presenting on novel anti-obesity and anti-diabetic properties of plants originating from the Boreal forest of Canada.
  • Dr. Peter Hyland: Professor, King's College, UK, presenting on novel standardization methods for polymolecular drugs.
  • Dr. Auro del Giallo, ABC Foundation School of Medicine, San Paulo Brazil presenting on polymolecular drugs and their role in treating cancer related fatigue
  • Dr. Jeffrey White, MD, Director, Office of Cancer Complementary and Alternative Medicine, National Cancer Institute, NIH, DHHS presenting on the US National Cancer Institute and its botanical research

Academic and clinical researchers, business development professionals and government agencies involved in the drug development field have been invited to attend and learn about this emerging field of health and therapeutics, and to network with other professionals in the field.


'/>"/>

Contact: Dr. Bhagirath Singh
bhagi.singh@schulich.uwo.ca
416-644-2287
CV Technologies Inc.
Source:Eurekalert

Related biology news :

1. An underwater drugstore?
2. Putting a bulls-eye on the flu: Paper details influenzas structure for future drug targeting
3. Shaping the future of the High Plains water supply
4. For future chips, smaller must also be better
5. ‘Scientific leaders of the future’ gear up for important talks on Capitol Hill
6. Lead-free piezoelectric materials of the future
7. Louisiana Tech forestry professor helps to shape future of global industry research
8. Glorious gadolinium gives flash memory a future
9. A future with or without trees
10. Unaccounted feedbacks from climate-induced ecosystem changes may increase future climate warming
11. Food for our future -- its more than whats for dinner
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/9/2016)... -- Elevay is currently known as the ... high net worth professionals seeking travel for work   ... there is still no substitute for a face-to-face meeting. ... deal with a firm handshake. This is why wealthy ... citizenship via investment programs like those offered by the ...
(Date:4/26/2016)... , April 27, 2016 ... "Global Multi-modal Biometrics Market 2016-2020"  report to their ... , The analysts forecast the global ... of 15.49% during the period 2016-2020.  ... of sectors such as the healthcare, BFSI, transportation, ...
(Date:4/13/2016)... -- IMPOWER physicians supporting Medicaid patients in Central ... in telehealth thanks to a new partnership with higi. ... patients can routinely track key health measurements, such as ... when they opt in, share them with IMPOWER clinicians ... retail location at no cost. By leveraging this data, ...
Breaking Biology News(10 mins):
(Date:6/23/2016)... ... June 23, 2016 , ... Supplyframe, the Industry Network for ... Design Lab . Located in Pasadena, Calif., the Design Lab’s mission is to ... are designed, built and brought to market. , The Design Lab is Supplyframe’s ...
(Date:6/23/2016)... NC (PRWEB) , ... June 23, 2016 , ... In ... University Hospital in Denmark detail how a patient who developed lymphedema after being treated ... tissue. The results could change the paradigm for dealing with this debilitating, frequent side ...
(Date:6/23/2016)... 23, 2016  Blueprint Bio, a company dedicated to ... medical community, has closed its Series A funding round, ... "We have received a commitment from Forentis ... need to meet our current goals," stated Matthew ... runway to complete validation on the current projects in ...
(Date:6/23/2016)... -- On Wednesday, June 22, 2016, the NASDAQ ... Dow Jones Industrial Average edged 0.27% lower to finish at ... Stock-Callers.com has initiated coverage on the following equities: Infinity Pharmaceuticals ... NKTR ), Aralez Pharmaceuticals Inc. (NASDAQ: ARLZ ... Learn more about these stocks by accessing their free trade ...
Breaking Biology Technology: